NBRx (New-to-Brand Prescription)
NBRx, or new-to-brand prescription, is a pharmaceutical sales metric counting prescriptions written for patients who are new to a particular brand, whether switching or starting therapy. It signals brand adoption momentum more sensitively than total prescription volume.
What is NBRx (New-to-Brand Prescription)?
NBRx, or new-to-brand prescription, is a pharmaceutical sales metric that counts prescriptions written for patients who are starting a particular brand for the first time, whether they are beginning therapy or switching from another product. It isolates fresh demand for the brand rather than counting all prescriptions filled.
This makes NBRx distinct from total prescription volume, which includes refills and continuing patients. By focusing on newly acquired patients, the metric captures the leading edge of a brand's uptake.
Why does NBRx matter in commercial analytics?
Because it reflects patients just beginning on a brand, NBRx tends to signal adoption momentum earlier and more sensitively than total prescription counts, which are weighted down by existing refills. A rising NBRx can indicate that marketing, access changes, or clinical evidence are successfully attracting new patients.
For market intelligence and commercial teams, NBRx is a forward-looking indicator used to gauge brand performance, evaluate launches, and assess competitive switching. It helps distinguish genuine growth in new patients from the inertia of an established prescription base.
- nbrx meaning
- new-to-brand prescription
- what is nbrx
- nbrx vs trx
- new to brand prescription metric
- nbrx pharma metric